Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-17

Clinical Trial Update: Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of Phytolacca decandra and Melissa officinalis in children with nocturnal bruxism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melissa officinalis (Melissa officinalis)
  • Phytolacca decandra (Phytolacca decandra)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Nocturnal Bruxism | Phase 3 | Status: UNKNOWN